Navigation Links
Oridion Announces Major Medical Research and Congress Presentations
Date:6/16/2008

JERUSALEM and NEEDHAM, Massachusetts, June 17 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. - (SWX: ORIDN) Significant findings from numerous medical research projects demonstrating the clinical benefit of end-tidal CO2 (EtCO2) monitoring using Microstream(R) capnography technology, were recently presented at medical congresses in the United States and Europe.

During Digestive Disease Week (DDW) in San Diego, California, Dr. Vargo, of the Cleveland Clinic, presented a blinded study that analyzed 122 randomized patients and showed that Microstream(R) capnography "significantly reduces the proportion of patients with hypoxemia, major hypoxemia, apnea and oxygen requirements during ERCP (Endoscopic Retrograde Cholangiopancreatography) and EUS (Endoscopic ultrasound).

Other studies describing the clinical value of Microstream(R) EtCO2 monitoring were presented during the European Resuscitation Council (ERC) in Ghent, Belgium and the European Society of Anesthesiology (ESA) in Copenhagen, Denmark. At ERC, two oral presentations were given and a Capnography Symposium took place with three distinguished clinicians and the clinical practice manager from London Ambulance Service. The four presentations showed the value of capnography in pre-hospital care (trauma, intubations, and ROSC). The Symposium was moderated by Prof. Pierre Carli, President Societe Francaise d'Anesthesie et de Reanimation (French Society of Anesthesia and Intensive Care).

Two medical presentations given at European Society of Anesthesia demonstrated the importance of capnography for non-intubated and intubated patients. In a study on the use of continuous non-invasive arterial CO2 estimation in spontaneously breathing patients after craniotomy, Dr. Wolter from France showed a good correlation between capnography and arterial blood gas analysis in sedated patients under regional anesthesia.

"These recent studies continue to confirm that patients are safer when their caregivers use Oridion Microstream(R) capnography technology," stated Gerry Feldman, President of Oridion Capnography. "The results of these global research projects clearly demonstrate that capnography improves patient safety and should be included in hospital and pre-hospital ventilatory monitoring strategies."

Oridion is the global leader of innovative capnography monitoring solutions helping to improve patient safety, and its Microstream(R) capnography technology has become the standard of care in ventilation monitoring.

A full list of these medical abstracts can be found on the Oridion website: http://www.oridion.com/global/english/clinical_solutions/overview/research. ht ml.
Next financial reporting:

August 18, 2008 Results Q2 / Half Year 2008

November 10, 2008 Results Q3 / Nine Months 2008

About Oridion Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

Certain statements made herein that are not historical are forward-looking. The words "estimate" "project" "intend" "expect" "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, our ability to maintain profits, the market demands for our Capnography products, our ability to focus our team on the Capnography business, changes in general economic and business conditions, inability to maintain market acceptance to the Company's products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for the Company's products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, factors effecting OEM partners' position in the market, inability to attract and retain qualified personnel, inability to protect the Company's proprietary technology.

For further information please contact:

Alan Adler, Chairman and Chief Executive Officer

Gerry Feldman, President

Walter Tabachnik, Chief Financial Officer

Elena Gerberg, Investor Relations

e-mail: investor@oridion.com

website : http://www.oridion.com

phone : +972-2-589-9159

address : Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel


'/>"/>
SOURCE Oridion Systems Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... DPLO ) is pleased to announce the promotion of Paul Urick to Senior Vice ... To learn more about our Diplomat executive team, click ... ... ... In his redefined role at Diplomat, Urick ...
(Date:2/12/2016)... , Feb. 12, 2016   HeartWare International, ... conference call and webcast to discuss its financial results ... 2015, on Thursday, February 25, 2016 at 8:00 a.m. ... prior to the conference call and webcast.  On the ... financial results, highlights from the fourth quarter and business ...
(Date:2/12/2016)... , Feb. 12, 2016  Sequent Medical, Inc. ... a study to evaluate the safety and effectiveness of ... treatment of ruptured intracranial aneurysms.  Prof Laurent Spelle ... in Paris, France and Principal ... France and Germany.  Although ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... According to an ... beginning to account for a significant portion of hernia repairs throughout the United States. ... Beverly Hills Hernia Center notes that this trend has not only been expected, but ...
(Date:2/12/2016)... ... 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , Feb. 25, 2016 ... Winston Churchill said, “Those who don’t learn from history are doomed to repeat it.” , ... come knocking this year. But that takes time. , Take a close look at ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a technology and ... the ISE Southeast Awards 2016. Finalists and winners of the ISE® Awards for ... Forum and Awards Gala on March 15, 2016 at the Westin Peachtree Plaza, ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ procurement organization ... a partnership with San Ramon Regional Medical Center. Under the collaboration, the first of ... way to accommodate a more certain time frame for donor families for the recovery ...
Breaking Medicine News(10 mins):